Full name
EXELTIS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.10.Z - Manufacture of basic pharmaceutical substances
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
46.90.Z - Non-specialised wholesale trade
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
64.92.Z - Other credit granting
72.19.Z - Other research and experimental development on natural sciences and engineering
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 3,3 | 5,8 | 75,2 |
EBITDA | 3,5 | 7,2 | 104,8 |
Short time liabilities | 8,5 | 15,4 | 82,3 |
Equity capital | 23,4 | 27,9 | 19,3 |
Operating profit (EBIT) | 2,9 | 6,5 | 120,2 |
Assets | 34,7 | 47,1 | 35,8 |
Net profit (loss) | 2,5 | 4,5 | 84 |
Cash | 0,7 | 1,9 | 175,8 |
Net income from sale | 61 | 81,8 | 34,1 |
Liabilities and provisions for liabilities | 11,2 | 19,1 | 70,1 |
Working assets | 21,1 | 33,6 | 59,6 |
Depreciation | 0,6 | 0,7 | 24,7 |
% | % | p.p. | |
Profitability of capital | 10,5 | 16,2 | 5,7 |
Equity capital to total assets | 67,5 | 59,3 | -8,2 |
Gross profit margin | 5,4 | 7,1 | 1,7 |
EBITDA Margin | 5,7 | 8,8 | 3,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 51 | 69 | 18 |
Current financial liquidity indicator | 1.9633731842041016 | 2.0053834915161133 | 0 |
Net dept to EBITDA | -0.19907517731189728 | -0.2681270241737366 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane